IP Library Granted Patent US 11,312,784
Granted Patent B2
US 11,312,784 · App. 16/309,969 · Granted Apr 26, 2022

IgG binding peptides and multifunctional antigen-binding proteins comprising the same

Inventors: Mark I. Greene (Penn Valley, PA); Hongtao Zhang (Paoli, PA); Zhiqiang Zhu (Philadelphia, PA); Lian Lam (Philadelphia, PA); Zheng Cai (Wynnewood, PA)
Assignee: The Trustees of the University of Pennsylvania
C07K16/2896A61P35/00C07K14/195C07K14/555C07K19/00A61K38/00C07K2317/622C07K2319/21C07K2319/30C07K2319/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,312,784
App. No.
16/309,969
Granted
Apr 26, 2022
Kind
B2
Abstract

Disclosed herein are multifunctional antigen-binding proteins comprising at least one multifunctional recombinant protein scaffold and at least one antigen-specific binding domain. Polynucleotides encoding the multifunctional antigen-binding proteins, vectors containing the disclosed polynucleotides, and cells that have been genetically engineered to express the polynucleotide are also provided. Methods of using the multifunctional antigen-binding proteins are disclosed.

Claims (30)

1. A multifunctional antigen-binding protein comprising, at least one multifunctional recombinant protein scaffold that binds to IgG and at least one antigen-specific binding domain,

wherein the at least one multifunctional recombinant protein scaffold that binds to IgG comprises a human polypeptide that contains mutations that enable the polypeptide to mimic the IgG binding domain of protein A,

wherein the at least one multifunctional recombinant protein scaffold comprises a polypeptide that is:

(a) at east 90% identical to huZZ as set forth in SEQ ID NO:28; or

(b) at least 90% identical to huZZ1 as set forth in SEQ ID NO:29; and

wherein the at least one antigen-specific binding domain comprises an antigen-specific peptide, an antigen-specific antibody or fragment thereof, or a combination thereof.

2. The multifunctional antigen-binding protein of claim 1 , wherein the at least one multifunctional recombinant protein scaffold that binds to IgG comprises a portion of an alpha2-macroglobulin receptor-associated protein.

3. The multifunctional antigen-binding protein of claim 1 , wherein the at least one multifunctional recombinant protein scaffold has the sequence set forth as SEQ ID NO:28 or SEQ ID NO:29.

4. The multifunctional antigen-binding protein of claim 1 , wherein the at least one multifunctional recombinant protein scaffold is linked to said antigen-specific binding domain and is capable of binding to a protein other than an antigen which can be hound by the antigen-specific binding domain.

5. The multifunctional antigen-binding protein of claim 1 , wherein the antigen-specific peptide comprises a polypeptide that is at least 90% identical to any one of SEQ ID NOs:12-24.

6. The multifunctional antigen-binding protein of claim 1 , wherein the antigen-specific antibody comprises a polypeptide that is at least 90% identical to 4D5scFv as set forth in SEQ ID NO:30.

7. The multifunctional antigen-binding protein of claim 6 , said multifunctional antigen-binding protein having an amino acid sequence that is:

(a) at least 90% identical to 4D5scFv-huZZ as set forth in SEQ NO:31; or

(b) at least 90% identical to 4D5scFv-huZZ1 as set forth in SEQ NO:32.

8. The multifunctional antigen-binding protein of claim 1 , further comprising a protein domain that promotes solubility.

9. The multifunctional antigen-binding protein of claim 1 , further comprising an epitope tag, a fluorophore, a radio isotope, an enzyme, or any combination thereof.

10. The multifunctional antigen-binding protein of claim 9 , wherein said epitope tag is a poly-histidine tag.

11. The multifunctional antigen-binding protein of claim 1 , further comprising a linker having one or more glycine residues, wherein said linker connects the at least one multifunctional recombinant protein scaffold to the at least one antigen-specific binding domain.

12. The multifunctional antigen-binding protein of claim 11 , wherein the linker comprises a polypeptide that is at least 90% identical to SEQ ID NO:25 or SEQ ID NO:26.

13. The multifunctional antigen-binding protein of claim 1 , further comprising an interferon (IFN) polypeptide or portion thereof.

14. The multifunctional antigen-binding protein of claim 13 , said multifunctional antigen-binding protein having an amino acid sequence that is:

(a) at least 90% identical to 4D5scFv-huZZ-hIFN as set forth in SEQ ID NO:33;

(b) at least 90% identical to 4D5scFv-huZZ-mIFN as set forth in SEQ ID NO:34;

(c) at least 90% identical to 4D5scFv-huZZ1-hIFN as set forth in SEQ ID NO:35; or

(d) at least 90% identical to 4D5scFv-huZZ1-mIFN as set forth in SEQ NO:36.

15. A polynucleotide encoding the multifunctional antigen-binding protein of claim 1 .

16. A cell that has been genetically engineered to express the polynucleotide of claim 15 .

17. A composition comprising the multifunctional antigen-binding protein of claim 1 and a pharmaceutically acceptable carrier.

18. A polypeptide comprising the sequence as set forth in SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ NO:34, SEQ ID NO:35, or SEQ ID NO:36.

19. A polynucleotide encoding the polypeptide of claim 18 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 20, 2021
From: UNIVERSITY OF PENNSYLVANIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057544/0177 →
Continuity (2)
Provisional Application 62351335 · Jun 17, 2016
Related Publication 20200216555A1 · Jul 9, 2020